244 related articles for article (PubMed ID: 1978872)
1. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
Wong CS; Pavord ID; Williams J; Britton JR; Tattersfield AE
Lancet; 1990 Dec; 336(8728):1396-9. PubMed ID: 1978872
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
[TBL] [Abstract][Full Text] [Related]
3. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
Deenstra M; Haalboom JR; Struyvenberg A
Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
[TBL] [Abstract][Full Text] [Related]
4. Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics.
Bremner P; Burgess C; Beasley R; Woodman K; Marshall S; Crane J; Pearce N
Respir Med; 1992 Sep; 86(5):419-23. PubMed ID: 1462021
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
[TBL] [Abstract][Full Text] [Related]
6. Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma.
Bauer KG; Kaik B; Sertl K; Kaik GA
Br J Clin Pharmacol; 1993 Oct; 36(4):285-92. PubMed ID: 12959305
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
Scalabrin DM; Solé D; Naspitz CK
J Asthma; 1996; 33(6):407-15. PubMed ID: 8968295
[TBL] [Abstract][Full Text] [Related]
8. The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.
Windom HH; Burgess CD; Siebers RW; Purdie G; Pearce N; Crane J; Beasley R
Clin Pharmacol Ther; 1990 Sep; 48(3):296-301. PubMed ID: 1976051
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Crane J; Burgess C; Beasley R
Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
[TBL] [Abstract][Full Text] [Related]
10. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Scheinin M; Koulu M; Laurikainen E; Allonen H
Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
[TBL] [Abstract][Full Text] [Related]
11. [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
Budmiger H; Kyd K; Scherrer M
Schweiz Med Wochenschr; 1978 Aug; 108(31):1190-7. PubMed ID: 675213
[TBL] [Abstract][Full Text] [Related]
12. A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients.
Bellamy D; Penketh A
Postgrad Med J; 1987 Jun; 63(740):459-61. PubMed ID: 3432172
[TBL] [Abstract][Full Text] [Related]
13. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.
Newhouse MT; Dolovich MB; Kazim F
Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
[TBL] [Abstract][Full Text] [Related]
16. Effects of airway calibre on lung delivery of nebulised salbutamol.
Lipworth BJ; Clark DJ
Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
[TBL] [Abstract][Full Text] [Related]
17. A dose response study comparing Duovent vs salbutamol.
Stewart DE; Gillies AJ
N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma.
Bauer K; Dietersdorfer F; Sertl K; Kaik B; Kaik G
Clin Pharmacol Ther; 1993 Jan; 53(1):76-83. PubMed ID: 8422745
[TBL] [Abstract][Full Text] [Related]
19. Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis.
Minette A; Marcq M; Gepts L
Bull Eur Physiopathol Respir; 1976; 12(4):545-53. PubMed ID: 13895
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the relative airways and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients.
Lipworth BJ; Newnham DM; Clark RA; Dhillon DP; Winter JH; McDevitt DG
Thorax; 1995 Jan; 50(1):54-61. PubMed ID: 7886650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
